Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques

Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques

BackgroundCardiovascular disease (CVD) is the foremost cause of morbidity and deaths in antiphospholipid syndrome (APS), driven by thrombo-inflammation and atherothrombosis mechanisms. Metabolic syndrome (MetS) is a proinflammatory and prothrombotic state characterized by increased CVD risk. We aime...

Celý popis

Podrobná bibliografie
Hlavní autoři: Eleana Bolla, Nikolaos Tentolouris, Petros P. Sfikakis, Maria G. Tektonidou
Médium: Článek
Jazyk:English
Vydáno: Frontiers Media S.A. 2023-01-01
Edice:Frontiers in Immunology
Témata:
antiphospholipid syndrome
metabolic syndrome
cardiovascular disease
atherosclerosis
thrombo-inflammation
cardiovascular risk factors
On-line přístup:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1077166/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1077166/full

Podobné jednotky